    <SEC-DOCUMENT>0001213900-24-066327-index.html : 20240808
    <SEC-HEADER>0001213900-24-066327.hdr.sgml : 20240808
    <ACCEPTANCE-DATETIME>20240808070648
    ACCESSION NUMBER:		0001213900-24-066327
    CONFORMED SUBMISSION TYPE:	8-K
    PUBLIC DOCUMENT COUNT:		24
    CONFORMED PERIOD OF REPORT:	20240808
    ITEM INFORMATION:		Regulation FD Disclosure
    ITEM INFORMATION:		Other Events
    ITEM INFORMATION:		Financial Statements and Exhibits
    FILED AS OF DATE:		20240808
    DATE AS OF CHANGE:		20240808

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Aldeyra Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001341235
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		8-K
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36332
    		FILM NUMBER:		241185984

    	BUSINESS ADDRESS:
    		STREET 1:		131 HARTWELL AVENUE
    		STREET 2:		SUITE 320
    		CITY:			LEXINGTON
    		STATE:			MA
    		ZIP:			02421
    		BUSINESS PHONE:		781-761-4904

    	MAIL ADDRESS:
    		STREET 1:		131 HARTWELL AVENUE
    		STREET 2:		SUITE 320
    		CITY:			LEXINGTON
    		STATE:			MA
    		ZIP:			02421

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Aldexa Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20130102

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Neuron Systems Inc
    		DATE OF NAME CHANGE:	20051012
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>8-K
    <SEQUENCE>1
    <FILENAME>ea0210840-8k_aldeyra.htm
    <DESCRIPTION>CURRENT REPORT
    <TEXT>
    Document 1 - file: ea0210840-8k_aldeyra.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.1
    <SEQUENCE>2
    <FILENAME>ea021084001ex99-1_aldeyra.htm
    <DESCRIPTION>ALDEYRA THERAPEUTICS, INC. PRESENTATION DATED AUGUST 8, 2024
    <TEXT>
    Document 2 - file: ea021084001ex99-1_aldeyra.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.2
    <SEQUENCE>3
    <FILENAME>ea021084001ex99-2_aldeyra.htm
    <DESCRIPTION>ALDEYRA THERAPEUTICS, INC. PRESS RELEASE DATED AUGUST 8, 2024
    <TEXT>
    Document 3 - file: ea021084001ex99-2_aldeyra.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>ex99-1_001.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: ex99-1_001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>5
    <FILENAME>ex99-1_002.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 5 - file: ex99-1_002.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>6
    <FILENAME>ex99-1_003.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 6 - file: ex99-1_003.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>7
    <FILENAME>ex99-1_004.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 7 - file: ex99-1_004.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>8
    <FILENAME>ex99-1_005.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 8 - file: ex99-1_005.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>9
    <FILENAME>ex99-1_006.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 9 - file: ex99-1_006.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>10
    <FILENAME>ex99-1_007.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 10 - file: ex99-1_007.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>11
    <FILENAME>ex99-1_008.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 11 - file: ex99-1_008.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>12
    <FILENAME>ex99-2_001.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 12 - file: ex99-2_001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.SCH
    <SEQUENCE>13
    <FILENAME>aldx-20240808.xsd
    <DESCRIPTION>XBRL SCHEMA FILE
    <TEXT>
    Document 13 - file: aldx-20240808.xsd

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.LAB
    <SEQUENCE>14
    <FILENAME>aldx-20240808_lab.xml
    <DESCRIPTION>XBRL LABEL FILE
    <TEXT>
    Document 14 - file: aldx-20240808_lab.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.PRE
    <SEQUENCE>15
    <FILENAME>aldx-20240808_pre.xml
    <DESCRIPTION>XBRL PRESENTATION FILE
    <TEXT>
    Document 15 - file: aldx-20240808_pre.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>17
    <FILENAME>R1.htm
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 17 - file: R1.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EXCEL
    <SEQUENCE>18
    <FILENAME>Financial_Report.xlsx
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 18 - file: Financial_Report.xlsx

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>19
    <FILENAME>Show.js
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 19 - file: Show.js

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>20
    <FILENAME>report.css
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 20 - file: report.css

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>22
    <FILENAME>FilingSummary.xml
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 22 - file: FilingSummary.html

    Document 22 - RAW XML: FilingSummary.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>JSON
    <SEQUENCE>24
    <FILENAME>MetaLinks.json
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 24 - file: MetaLinks.json

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>ZIP
    <SEQUENCE>25
    <FILENAME>0001213900-24-066327-xbrl.zip
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 25 - file: 0001213900-24-066327-xbrl.zip

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>26
    <FILENAME>ea0210840-8k_aldeyra_htm.xml
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 26 - file: ea0210840-8k_aldeyra_htm.html

    Document 26 - RAW XML: ea0210840-8k_aldeyra_htm.xml

    </DOCUMENT>
    </SEC-DOCUMENT>